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Background: Toxocara canis is an intestinal nematode affecting dogs and cats, which causes 
human infection when embryonated eggs excreted in dog feces are ingested. Humans are 
paratenic hosts. Although the larvae do not develop into adult worms in the human body, they 
may migrate to various tissues and organs where they can survive for several years, giving rise 
to several clinical symptoms, which can present in allergy-like form.
Methods: Over 5 years, we examined 9985 patients referred for suspected allergies, based on 
symptoms such as dermatitis, urticaria, rhinitis, asthma, and conjunctivitis; 753 patients who 
had allergy tests negative or unrelated to clinical history were tested for seropositivity to T. canis 
by enzyme-linked immunosorbent assay (ELISA) or Western blotting (WB).
Results: In 240 patients (31.8%), ELISA or WB or both tests were positive for T. canis immu-
noglobulin G (IgG) antibodies: in particular, 64 of them (26.7%) were positive to ELISA, 
110 (45.8%) to WB, and 66 (27.5%) to both tests. Asthma was the most common clinical 
presentation. Two thirds of patients underwent subsequent anthelmintic therapy and showed a 
complete remission of symptoms and, in 43% of patients retested by ELISA and WB, became 
negative to Toxocara.
Conclusion: These findings strongly suggest that T. canis plays a significant role in inducing 
chronic symptoms presenting as suspected allergies.
Keywords: suspected allergy, Toxocara canis, enzyme-linked immunosorbent assay, Western 
blotting, anthelmintic therapy
Introduction
Allergic diseases in Western countries have steadily increased over the last 20 years, 
affecting the respiratory system, conjunctiva, and skin.1,2 Moreover, an emergent aspect 
is the association of gastrointestinal involvement with respiratory and/or cutaneous 
symptoms, arising from allergies and/or intolerance. Gastroenteric expressions of 
these diseases include acute symptoms (diarrhea or vomiting) and chronic symptoms 
(bloating, constipation which may alternate with diarrhea). Allergy tests, performed 
with commercial extracts or fresh foods, can be negative or slightly positive in most 
patients in both situations.3 Allergy tests may also be negative in respiratory and 
cutaneous allergy, and this enables a distinction between, eg, allergic and nonallergic 
asthma, allergic and nonallergic rhinitis, and allergic and nonallergic dermatitis.4
Different explanations for this increase in prevalence have been hypothesized, 
  including genetic predisposition,5,6 environmental factors,7,8 or the “hygiene hypothesis”,9 
but none of these possibilities seems to be completely satisfactory. In this context, 
since the role of immunoglobulin E (IgE) antibodies is central to the development of 
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allergies, factors related to the onset of symptoms must also 
include the possibility of helmintic infections, which induce 
high IgE levels. The IgE increase is proportional to both the 
severity of infection and invasion of parasites in the tissues, 
and is the sum of the total IgE level plus parasite-specific IgE 
release.10,11 The latter derives from helmintic production of 
factors that stimulate interleukin-4 production.12 In particular, 
one study found an increase in circulating IgE levels during 
parasitic infections caused by Ascarids,13 while other studies 
demonstrated a total IgE increase in parasitic diseases and 
their reduction after antiparasitic therapy,14 as well as high 
IgE levels in patients affected by visceral larva migrans 
with antibodies against Toxocara.15 The infestation caused 
by Toxocara canis appears to be very frequent in tropical 
countries, but also in some areas in Europe, especially among 
children in the first decade of life.16,17 The symptoms caused 
by Toxocara infection in the different target organs in the 
respiratory, cutaneous, and gastrointestinal systems are often 
similar to the symptoms of allergic diseases. The aim of the 
present study was to evaluate the prevalence of seropositiv-
ity to T. canis in a large population of patients referred for 
symptoms of suspected allergy.
Methods and materials
Between 2003 and 2008, we evaluated 9985 new patients 
presenting with symptoms suggesting an allergic disease. The 
clinical symptoms involved seasonal or persistent rhinocon-
junctivitis, asthma, urticaria, angioedema, and dermatitis.
All patients underwent clinical examination, careful evalu-
ation of symptoms, and allergy tests, including skin prick 
tests with inhaled or food allergen extracts and, in patients 
with dermatitis, patch tests with a standard panel of haptens 
(Merck, Milan, Italy). Skin prick tests were performed with the 
panel of allergen extracts from Stallergenes, Milan, Italy.
Routine and immunological blood tests and parasitological 
tests on feces were performed, as well as symptomatic therapy, 
environmental prophylaxis as preventive treatment, an exclu-
sion diet when food allergy was suspected, and replacement 
of medication(s) when a drug allergy was suspected.
A subgroup comprising 753 patients was selected who 
suffered from chronic recurrent respiratory, eye, skin or 
gastrointestinal symptoms caused by nonallergic mecha-
nisms, as assessed by results to allergy tests negative or 
unrelated to clinical history, and these patients underwent 
further hematochemical and immunological blood tests, ie, 
enzyme-linked immunosorbent assay (ELISA), measured 
in optical density (OD) with a range from 0.9 to 1.1, and 
Western blotting (WB) tests for IgG antibodies to T. canis, 
using material from LTBio Diagnostics, Lyon, France. The 
results of WB were interpreted as shown in Figure 1. These 
patients mainly suffered from asthma, urticaria, dermatitis, 
and conjunctivitis; less frequently they suffered from gas-
troenteric symptoms, asthenia, headache, dizziness, or drug 
reactions. The prevalence of the different clinical presenta-
tions was compared using the Chi-squared test.
Anthelmintic therapy was prescribed for T. canis sero-
positive patients, using mebendazole (one 100 mg tablet 
twice daily for 3 days, 5 mL syrup twice daily in children), 
repeated after 20 days up to three times in an effort to 
achieve significant symptomatic improvement. In the event 
of lack of improvement, albendazole (one 400 mg tablet 
twice daily for 5 days in adults, 5 mg/kg divided in two 
half doses in children) was used, and repeated after two 
months. Drugs for symptomatic therapy were also prescribed. 
These were mainly antihistamines or topical steroids for 
rhinitis symptoms, inhaled beta-agonists and corticoster-
oids for asthma symptoms, antihistamines, and topical 
or systemic   corticosteroids for skin symptoms, including 
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Figure  1  Western  blot-specific  IgG  anti-Toxocara  canis.  Low  molecular  weight 
zone is Toxocara-specific. The presence on the strip of two or more low molecular 
weight bands in the range of 24–35 kDa is indicative of the presence of specific anti-
Toxocara IgG in the sample.
Abbreviations:  kDa,  kiloDalton;  nEG,  negative;  POS,  positive;  hMW,  high 
molecular weight; LMW, low molecular weight.
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urticaria/  angioedema,   dermatitis and itching, and   probiotics 
(  Lactobacillus reuteri) for intestinal symptoms. Regular 
control visits were scheduled, the first after 2 months and 
subsequently every 4 months. Patients who did not come back 
for the checkup visit were contacted by telephone about their 
symptoms. Clinical evaluations of symptoms and serological 
tests with the WB and ELISA for antibodies to T. canis were 
performed in patients who came to the visits. The study was 
registered (EudraCT number 2010-024221-20) and approved 
by local authorities. Informed consent was sought from all 
patients eligible for anthelmintic therapy.
Results
In the selected group of 753 patients suffering from chronic 
recurrent symptoms caused by nonallergic mechanisms, 
240 (31.8%) tested positive for T. canis by ELISA, WB, or both 
tests; 64 of them (26.7%) were positive to ELISA, 110 (45.8%) 
to WB, and 66 (27.5%) to both tests. These patients included 
222 adults (150 females, 72 males, age range 18–72 years) and 
18 children (seven females, 11 males, age range 2–17 years).
Sixty-two of the 753 patients (25.8%) had animals at 
home (28 had a cat, 23 had a dog, and 11 had both animals). 
Fifty-two patients (23.3%) were atopic, with positive results 
to skin prick testing that were unrelated to clinical symptoms; 
in these patients, the mean level of total IgE was 280 kU/L. 
In the 188 nonatopic patients, the mean level of total IgE 
was 193 kU/L.
The clinical presentations of the patients are reported in 
Table 1. Asthma was significantly more frequent compared 
with the other presentations (P = 0.029 versus urticaria, 
P = 0.002 versus dermatitis, P , 0.0001 versus each other 
presentation). Among patients with asthma, five had level I, 
30 had level II, 16 had level III, and eight patients had level 
IV disease according to the Global INitiative for Asthma 
(GINA) classification. Of the 240 T. canis seropositive 
patients, 162 (67.5%) agreed to undergo anthelmintic therapy, 
which resulted in considerable improvement in symptoms. 
Eighty-eight patients did not come for the checkup visit, but 
they were contacted by phone and confirmed that they did not 
suffer from symptoms any longer and did not use any more 
symptomatic drugs. In 14 of the 74 patients who came back 
to the scheduled control visits, we observed both clinical and 
serological improvement in WB and ELISA tests. In six of 
these patients, a decrease in the size of bands using WB was 
found; in five patients, the size of bands using WB and the 
OD using ELISA decreased, and ELISA OD values decreased 
from .1.1 to negative values in the range of 0.9–1.0 in three 
patients. There was a complete remission of symptoms 
with complete absence of antibodies to T. canis in 26 of the 
74 patients. Table 2 shows the results of WB and ELISA.
Discussion
Because we have previously observed cases of T. canis 
  infection that simulated allergic manifestations and were 
mistakenly considered allergies for a long time,18 we system-
atically tested allergic patients referred for suspected allergy 
(who had negative allergy tests or test results clearly unrelated 
to history) for seropositivity to T. canis. Of 753 patients with 
such characteristics, 240 (32%) were positive using in vitro 
tests (ELISA or WB) for IgG antibodies to T. canis. The role 
of T. canis infection in sustaining the symptoms was further 
demonstrated by the efficacy of anthelmintic treatment, which 
was evident in more than two thirds of treated patients and 
was associated with negativization or a decrease in Toxocara 
IgG antibodies in 43% of patients who underwent repeat 
ELISA or WB.
Human toxocariasis is a zoonosis sustained by parasitic 
infestation with the nematode T. canis belonging to the 
order of Ascaris, which infects dogs, cats, and many other 
  mammals. A human host is occasionally infected via acciden-
tal ingestion of embryonated eggs in dirt. This happens mainly 
among children when they ingest soil while playing or eating. 
In human hosts, the larvae do not develop into adults, but they 
can migrate to different organs and tissues and survive for 
long periods of time, varying from a few months to decades, 
depending on the host immune response.19
The real incidence/prevalence of this infestation in 
humans has not yet been assessed, because the disease induces 
Table 1 Clinical presentation of patients positive to Toxocara canis
Patients  
n (%)
Clinical  
presentation
Prevalence in  
selected population
59 (24.6) Asthma 7.8%
36 (15) Urticaria 4.8%
28 (11.7) Dermatitis 3.7%
19 (7.9) Conjunctivitis 2.5%
13 (5.4) Colitis 1.7%
12 (5) headache 1.6%
12 (5) Asthenia 1.6%
11 (4.6) Cough 1.5%
10 (4.2) Dysphagia/angioedema 1.3%
8 (3.3) Itching 1.10%
7 (2.9) Rhinitis 0.9%
15 (6.2) neurological symptoms  
(4 MS, 2 ataxia, 1 SLA,  
3 ADhD, 5 epilepsy)
1.9%
10 (4.2) Other symptoms 1.3%
Abbreviations:  MS,  multiple  sclerosis;  SLA,  systemic  lupus  erythematosus; 
ADHD, attention deficit hyperactivity syndrome.
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migrans, limited to the eye, and may cause a reduction in 
sight, conjunctival hyperemia, recurrent conjunctivitis, and 
even granulomas, uveitis, and retinal   detachment. The last 
one is visceral larva migrans, and its symptoms include fever, 
asthenia, behavioral   depression (suggesting central nervous 
system   involvement), skin afflictions like nodules, chronic 
hives, recurrent labial and eyelid angioedema and eczematous 
dermatitis, enteric symptoms such as meteorism and abdomi-
nal pain,   respiratory symptoms such as dyspnea, persistent 
cough, recurrent asthmatic and bronchitic manifestations, 
pleuritis, and bronchopneumonia.17,19
Epidemiological studies conducted in Europe have shown 
variable prevalence of seropositivity for T. canis. In Spain, 14% 
of both pediatric and adult patients were found to suffer from 
eosinophilia, and 6% of these patients showed eye   disorders.20 
In Sweden, the prevalence of seropositivity was about 7%, 
indicating a relevant presence of subclinical   toxocariasis. 
In this group, eosinophilia was recognized in 32% of the 
sample, and the most common clinical manifestation was eye 
problems (46%) while neurological, respiratory and hepatic 
symptoms were described in 40% of these patients.21
In an Italian study that included 2112 healthy adult 
  subjects, the prevalence of T. canis antibody seropositivity 
was 3.9%. The percentage increased in the control group of 
471 nonhealthy subjects (257 affected by epilepsy, 142 by 
  oligophrenia, 76 by Strongyloides stercoralis   infestation), 
and was 4.35% in epilepsy patients, 9.2% in patients 
with strongyloidiasis, and 10.6%–14.5% in subjects with 
  oligophrenia.22 Thirty-one of 100 Toxocara-positive pediatric 
patients suffered from asthma or bronchitis, while the percent-
age decreased to only 12% among Toxocara-seronegative 
patients in a study performed in The Netherlands.23
Toxocara infestation mainly occurs via accidental inges-
tion of soil, that is why the illness usually affects children, 
but adults can also be infected. As stated above, the larvae 
do not develop in the human host but only migrate to differ-
ent organs and tissues, where they survive for a certain time 
period depending on the level of the host immune response. 
Clinical manifestations can be nonspecific and difficult to 
recognize. They may even cause symptoms similar to viral 
infections or allergy-like symptoms, ie, may present with the 
clinical expression of allergy.
Symptoms can be mild, including fever, recurrent hacking 
cough, dyspnea, recurrent bronchitis, pleuritis, broncho-
pneumonia, asthma, skin afflictions like nodules and chronic 
hives, recurrent labial and eyelid angioedema and eczema-
tous dermatitis, enteric symptoms, or even symptoms 
limited to the eye causing conjunctiva hyperemia and 
Table 2 Changes in anti-Toxocara IgG antibodies as measured 
by ELISA and WB following anthelmintic treatment in clinically 
improved patients
Patient Before treatment  
ELISA WB
After treatment   
ELISA WB
1 1.06 negative ,0.9 negative
2 .1.1 negative ,0.9 negative
3 .1.1 negative ,0.9 negative
4 1.04 negative ,0.9 negative
5 0.92 negative ,0.9 negative
6 .1.1 negative ,0.9 negative
7 1.00 negative ,0.9 negative
8 .1.1 negative ,0.9 negative
9 .1.1 negative ,0.9 negative
10 ,0.9 faint bands ,0.9 negative
11 ,0.9 faint bands ,0.9 negative
12 ,0.9 faint bands ,0.9 negative
13 ,0.9 faint bands ,0.9 negative
14 ,0.9 faint bands ,0.9 negative
15 ,0.9 faint bands ,0.9 negative
16 ,0.9 faint bands ,0.9 negative
17 ,0.9 faint bands ,0.9 negative
18 ,0.9 faint bands ,0.9 negative
19 ,0.9 faint bands ,0.9 negative
20 ,0.9 faint bands ,0.9 negative
21 ,0.9 heavy bands ,0.9 negative
22 ,0.9 heavy bands ,0.9 negative
23 1.00 faint bands ,0.9 negative
24 .1.1 faint bands ,0.9 negative
25 .1.1 faint bands ,0.9 negative
26 .1.1 negative ,0.9 negative
27 .1.1 heavy bands ,0.9 faint bands
28 .1.1 heavy bands 1.08 heavy bands
29 ,0.9 heavy bands ,0.9 faint bands
30 1.30 heavy bands ,0.9 faint bands
31 .1.1 heavy bands 0.99 heavy bands
32 .1.1 heavy bands ,0.9 faint bands
33 .1.1 heavy bands .1.1 faint bands
34 .1.1 faint bands 0.99 negative
35 ,0.9 heavy bands ,0.9 faint bands
36 1.00 faint bands ,0.9 faint bands
37 ,0.9 heavy bands ,0.9 faint bands
38 .1.1 heavy bands .1.1 faint bands
39 .1.1 heavy bands ,0.9 faint bands
40 .1.1 heavy bands .1.1 negative
Abbreviations: ELISA, enzyme-linked immunosorbent assay; WB, Western blotting.
nonspecific symptoms. However, sometimes it   mimics a viral 
infection, and in the mildest cases can be totally asymptomatic. 
Symptoms are classified based on three clinical outlines. The 
first one is called capsulated toxocariasis, which is character-
ized by very mild symptoms, with no clear clinical manifesta-
tions (for example, nonspecific illness with fever, recurrent 
hacking cough, insomnia, abdominal pain, headache, and 
behavioral disorders). The second one is called ocular larva 
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recurrent conjunctivitis.18,19 Most of these symptoms were 
present in the population we studied, in particular asthma, 
which was significantly more frequent than any other   clinical 
presentation in patients with positive in vitro tests for 
  Toxocara. This reinforces the suggestion made by Cooper 
that T. canis is an important and neglected environmental 
risk factor for asthma.24 The role of T. canis infection may be 
assessed by the detection of specific IgG antibodies, it being 
known that the IgG4 subclass is predominantly involved in 
the response to parasitic infections.25
Conclusion
The findings from this study indicate that T. canis infection, 
as assessed by seropositivity of IgG antibodies by ELISA 
or WB, is not rare in patients presenting with symptoms of 
apparent allergy but with negative or inconclusive allergy 
tests. This suggests that serological tests should be performed 
to detect Toxocara-specific IgG antibodies in such patients 
and to assess the effect of anthelmintic treatment, in an effort 
to diagnose parasitic infection correctly in patients who are 
otherwise given a simple (but incorrect) diagnosis of nonal-
lergic disease.
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